Moreover, cfDNA could predict HCC recurrence, that is, the patients with recurrent HCC showed significantly higher somatic mutation frequency of cfDNA than those without recurrence, of which the TP53 gene was the most frequently mutated gene in majority of the HCC patients (21/33, 64%). Here, TP53 is linked to hepatocellular carcinoma.